Abstract: Granulomatous mycosis fungoides is a rare subtype of T-cell cutaneous lymphoma. Due to its clinical heterogenicity the diagnosis is delayed and based on histopathological and immuno-histochemical fi ndings, sometimes requiring gene rearrangement studies for confi rmation. We report the case of a patient who was submitted to several biopsies before diagnostic conclusion.
INTRODUCTION
Granuloma formation has been reported in various types of lymphomas such as Sézary syndrome, cutaneous anaplastic large cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma, primary cutaneous B-cell lymphoma. However, mycosis fungoides is the most common form of primary cuta-neous lymphoma which may present granulomatous infi ltrate. 1 Due to the fact that it lacks a specifi c clinical feature and that the granulomatous infl ammatory infi l-trate sometimes is extensive, this disease may be mistakenly diagnosed as granulomatous dermatitis, and the diagnosis of lymphoma may be postponed.
CASE REPORT
A 88-year-old female patient presented with an asymptomatic erythematous plaque on her neckline, which had developed 2 years previously. She was diagnosed with profound mycosis, and used medium-power topical steroids and topical and oral antifungal azole, with no improvement.
The patient fi rst visited our hospital 6 months ago, when we found a 20 x12cm erythematousviolet plaque with yellowish milia-type papules and telangiectasia in the anterior chest region. Subsequently she developed purpuric lesions in the vicinity of the lesion ( Figure 1 )
Three histopathological examinations of the lesion were performed, and the fi rst two showed granu-lomatous reaction with epithelial cells in the reticular dermis (Figures 2 and 3 ). The special stains performed (Fite, Grocott, PAS) failed to show microorganisms. The last histopathological examination revealed, other than the tuberculoid granuloma, an area of epidermotropism ( Figure 4 ). The immunohistochemical study was positive for CD3-, CD4-, and CD5-lymphocytes and weakly positive for CD8. The study showed no immunostaining for CD30.
Blood count, complete biochemical profi le, electrolytes, protein immunoelectrophoresis, PPD, com-puted tomography of the chest and abdomen, cervical spine X-ray and biopsy of abdominal fat were all normal.
The initially proposed treatment was highpower topical steroids, but the patient stopped to attend the follow-up visits.
DISCUSSION
Mycosis fungoides granulomatous was fi rst described by Ackerman and Flaxman in 1970. 1, 2 Histopathologically, it is characterized by diffuse infi ltration of the dermis by lymphoid cells with hyperconvoluted nuclei and interspersed with granulomatous infl ammatory foci with epithelioid and giant cells. It is more common in males between the 5th and 6th decades of life. Clinical presentation is variable. It may present as papules, plaques or ulcerated nodules. 2 The diagnosis of mycosis fungoides granulomatous is established after a granulomatous infi ltrate is seen. Occasionally, a dense infl ammatory infi ltrate with pleomorphic atypical lymphocytes is present in the subcutaneous area. Epidermotropism is considered a critical fi nding to make this diagnosis. When there is no epidermotropism, diagnostic delay is, on average, nine years and the diagnosis is usually only made after several biopsies.
2.3
Various granulomatous histopathological patterns are associated with cutaneous lymphoma, the most common being the epithelioid. However, there are reports in the literature about forms that also mimic annular granuloma, lipoid necrobiosis, granulomatous rosacea and granulomatous panniculitis. More than one pattern may coexist in the same patient. 1, 3, 4, 5 The etiopathogenic mechanism of granuloma formation is unknown. It was suggested that the granulomatous reaction occurs due to the secretion of chemotactic factors by neoplastic cells. A polarization to produce Th1 cytokines, such as interleukin-2, interferon-gamma, and tumor necrosis factor-alpha, may also occur. On the other hand, the granuloma may precede the lymphoma, with macrophages producing interleukin-6, which promotes lymphocyte proliferation. 4 
